VIVO
Meridian Bioscience Inc
VIVO
VIVO
Delisted
VIVO was delisted on the 30th of January, 2023.
210 hedge funds and large institutions have $1.11B invested in Meridian Bioscience Inc in 2022 Q1 according to their latest regulatory filings, with 47 funds opening new positions, 62 increasing their positions, 68 reducing their positions, and 17 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
9% less repeat investments, than reductions
Existing positions increased: 62 | Existing positions reduced: 68
50% less funds holding in top 10
Funds holding in top 10: 4 → 2 (-2)
Holders
210
Holding in Top 10
2
Calls
$5.95M
Puts
$1.58M
Top Buyers
| 1 | +$104M | |
| 2 | +$5.13M | |
| 3 | +$4.54M | |
| 4 |
Aviva
London,
United Kingdom
|
+$2.24M |
| 5 |
EIP
Epoch Investment Partners
New York
|
+$1.46M |
Top Sellers
| 1 | -$23M | |
| 2 | -$6.74M | |
| 3 | -$5.53M | |
| 4 |
RA
Royce & Associates
New York
|
-$4.63M |
| 5 |
CEI
Clark Estates Inc
New York
|
-$4.49M |